Published in Lancet on January 20, 1990
DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother (1995) 2.57
High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan. Genitourin Med (1994) 2.20
Surveillance of antibiotic resistance in clinical isolates of Neisseria gonorrhoeae. BMJ (1991) 1.98
Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin. Antimicrob Agents Chemother (1995) 1.57
Global fluoroquinolone resistance epidemiology and implictions for clinical use. Interdiscip Perspect Infect Dis (2012) 1.55
Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin. J Clin Microbiol (1991) 1.55
Laboratory detection of ciprofloxacin resistant Neisseria gonorrhoeae. J Clin Pathol (1991) 1.40
Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993. Antimicrob Agents Chemother (1994) 1.37
Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia. Antimicrob Agents Chemother (1990) 1.32
Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan. Antimicrob Agents Chemother (1995) 1.27
Fluoroquinolone resistance in Neisseria gonorrhoeae. Emerg Infect Dis (1997) 1.25
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in The Netherlands, 1977-95. Genitourin Med (1997) 1.23
The changing pattern of antibiotic resistance of Neisseria gonorrhoeae. Genitourin Med (1990) 1.18
Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro. Sex Transm Infect (1998) 1.15
Rapid detection of point mutations of the Neisseria gonorrhoeae gyrA gene associated with decreased susceptibilities to quinolones. J Clin Microbiol (1996) 1.08
Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure. Antimicrob Agents Chemother (1998) 1.06
Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. The Pazufloxacin STD Group. Antimicrob Agents Chemother (1998) 1.06
Reduced uptake and accumulation of norfloxacin in resistant strains of Neisseria gonorrhoeae isolated in Japan. Genitourin Med (1994) 1.05
Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline. Genitourin Med (1995) 1.03
In vitro activity of a new fluoroquinolone, CP-99,219, against strains of Neisseria gonorrhoeae. Antimicrob Agents Chemother (1995) 1.02
Rapid screening of point mutations of the Neisseria gonorrhoeae parC gene associated with resistance to quinolones. J Clin Microbiol (1997) 0.98
Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin. Antimicrob Agents Chemother (1995) 0.92
Detection of quinolone-resistant Neisseria gonorrhoeae. J Clin Microbiol (1996) 0.87
Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium. J Clin Microbiol (1992) 0.86
Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males [corrected]. Genitourin Med (1992) 0.84
Disk diffusion method for susceptibility testing of Neisseria gonorrhoeae. J Clin Microbiol (1991) 0.83
Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria gonorrhoeae. Genitourin Med (1996) 0.83
The use of fluoroquinolones in sexually transmitted diseases in Southeast Asia. Drugs (1995) 0.81
Ciprofloxacin resistant Neisseria gonorrhoeae. Genitourin Med (1995) 0.80
Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline. Genitourin Med (1995) 0.78
Quinolones in sexually transmitted diseases. Drugs (1993) 0.77
Continuous surveillance of antibiotic resistant Neisseria gonorrhoeae: A tool to forewarn emerging trends in resistance. Can J Infect Dis (1995) 0.75
National microbiological surveillance of the susceptibility of gonococcal isolates to antimicrobial agents. Can J Infect Dis (1992) 0.75
Efficacy and safety of single oral dose sparfloxacin vs ciprofloxacin in acute gonococcal urethritis in males. A multicentre international study. Drugs (1995) 0.75
Quinolones in sexually transmitted diseases. Global experience. Drugs (1995) 0.75
Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin. Lancet (1990) 6.99
Neisseria gonorrhoeae 3. Demonstration of presumed appendages to cells from different colony types. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 8.94
Neisseria gonorrhoeae. Colony variation I. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 4.03
Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell (2001) 3.34
Outbreak of giardiasis associated with mains water in the United Kingdom. Lancet (1986) 2.65
How to reduce the stress of general dental practice: the need for research into the effectiveness of multifaceted interventions. Br Dent J (2006) 2.64
UK National Guidelines on the Management of Syphilis 2008. Int J STD AIDS (2008) 2.53
Cryptosporidiosis in an urban community. Br Med J (Clin Res Ed) (1984) 2.34
Penicillin-binding protein 2 genes of non-beta-lactamase-producing, penicillin-resistant strains of Neisseria gonorrhoeae. Mol Microbiol (1989) 2.09
Locally acquired heterosexual outbreak of syphilis in Bristol. Lancet (1997) 2.09
Family pesticide use and childhood brain cancer. Arch Environ Contam Toxicol (1993) 2.04
An outbreak of meningococcal disease in Stonehouse: planning and execution of a large-scale survey. Epidemiol Infect (1987) 1.95
The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products. PLUS. Vox Sang (2010) 1.91
Diagnosis of gonorrhoea in women. Role of the rectal sample. Br J Vener Dis (1974) 1.87
Pharmacokinetics of ketoconazole in normal subjects. J Antimicrob Chemother (1981) 1.84
The differential assessment of children's attention: the Test of Everyday Attention for Children (TEA-Ch), normative sample and ADHD performance. J Child Psychol Psychiatry (2001) 1.80
Use of transport-and-culture medium combined with immunofluorescence for the diagnosis of gonorrhoea. Lancet (1974) 1.78
Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer (2008) 1.77
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. J Med Genet (2009) 1.74
Computer-assisted rapid enzyme-linked immunosorbent assay (ELISA) in the serological diagnosis of aspergillosis. J Immunol Methods (1983) 1.70
Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation (1997) 1.60
Cavernous sinus thrombosis. J Neurol Neurosurg Psychiatry (1982) 1.58
The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products. Vox Sang (2011) 1.57
Comparison of high performance liquid chromatographic and microbiological methods for determination of itraconazole. J Antimicrob Chemother (1988) 1.54
Ciprofloxacin resistant Neisseria gonorrhoeae in the UK. Genitourin Med (1990) 1.53
Preliminary study of colony type stability of Neisseria gonorrhoeae in liquid culture. Br J Vener Dis (1972) 1.51
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. Mol Immunol (1993) 1.50
Comparative in vitro activity of semisynthetic penicillins against Proteeae. Antimicrob Agents Chemother (1983) 1.48
22q11 deletion and polymicrogyria--cause or coincidence? Clin Dysmorphol (2000) 1.47
The weak immunogenicity of Fusobacterium necrophorum. J Hyg (Lond) (1985) 1.46
Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States) Cancer Causes Control (1998) 1.46
Penicillin sensitivity of gonococci. An evaluation of monitoring as an index of epidemiological control. Br J Vener Dis (1976) 1.45
Seven year follow up of children presenting to the accident and emergency department with irritable hip. J Accid Emerg Med (1999) 1.42
Behavior of resting Aedes aegypti (Culicidae: Diptera) and its relation to ultra-low volume adulticide efficacy in Panama City, Panama. J Med Entomol (2000) 1.41
Isolation of neisseria lactamicus from a genital site. Lancet (1972) 1.41
Laboratory detection of ciprofloxacin resistant Neisseria gonorrhoeae. J Clin Pathol (1991) 1.40
Whole-exome sequencing and an iPSC-derived cardiomyocyte model provides a powerful platform for gene discovery in left ventricular hypertrophy. Front Genet (2012) 1.40
Non-toxigenic Corynebacterium diphtheriae in a boarding school. Lancet (1975) 1.37
Penicillinase-producing gonococci in Britain. Lancet (1981) 1.37
Factors affecting the toxicity of rotting carcasses containing Clostridium botulinum type C. Epidemiol Infect (1987) 1.34
Antibiotic-loaded acrylic cement. J Bone Joint Surg Br (1977) 1.34
An unusual outbreak of food-poisoning associated with meals-on-wheels. Lancet (1977) 1.32
Laterality and the growth of intellectual abilities. Br J Educ Psychol (1974) 1.31
Diagnosis of gonorrhoea in women: comparison of sampling sites. Br Med J (1973) 1.30
Improved tumor targeting with chemically cross-linked recombinant antibody fragments. Cancer Res (1994) 1.24
A multiplex polymerase chain reaction to differentiate beta-lactamase plasmids of neisseria gonorrhoeae. J Antimicrob Chemother (2000) 1.24
Aligned microcontact printing of micrometer-scale poly-L-lysine structures for controlled growth of cultured neurons on planar microelectrode arrays. IEEE Trans Biomed Eng (2000) 1.24
Neisseria gonorrhoeae. Colony variation II. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 1.22
STING: a soft-tissue intervention and neurosurgical guide to access deep brain lesions through curved trajectories. Proc Inst Mech Eng H (2010) 1.20
Effect of dietary alpha-linolenic acid on thrombotic risk factors in vegetarian men. Am J Clin Nutr (1999) 1.20
Improved transport and culture system for the rapid diagnosis of gonorrhoea. Br J Vener Dis (1976) 1.18
Early TPHA response in primary syphilis. Br J Vener Dis (1977) 1.17
Spread of Neisseria gonorrhoeae resistant to tetracycline outside the United States of America. Br Med J (Clin Res Ed) (1988) 1.16
Community-based malaria control in Saradidi, Kenya: description of the programme and impact on parasitaemia rates and antimalarial antibodies. Ann Trop Med Parasitol (1987) 1.16
Salmonella excretion by pet terrapins. J Hyg (Lond) (1969) 1.15
Susceptibility of wallabies to Fusobacterium necrophorum. Vet Rec (1986) 1.15
Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire. J Infect (1990) 1.13
Ondansetron with and without dexamethasone to treat chemotherapy-induced emesis. Lancet (1989) 1.11
Person-to-person spread of Salmonella typhimurium phage type 10 after a common-source outbreak. Lancet (1981) 1.11
Improved management in the diagnosis of gonorrhoea in women. Br J Vener Dis (1978) 1.10
Reversion of Kellogg's colonial types of Neisseria gonorrhoeae in liquid medium. J Med Microbiol (1977) 1.08
Molecular evolution of tetracycline-resistance plasmids carrying TetM found in Neisseria gonorrhoeae from different countries. J Antimicrob Chemother (1991) 1.08
Growth, behavior, and clinical findings in 27 patients with Kabuki (Niikawa-Kuroki) syndrome. Am J Med Genet A (2004) 1.07
Extraocular palsy and thiamine therapy in Wernicke's encephalopathy. Am J Clin Nutr (1969) 1.07
Outbreaks of hospital infection in southwest England caused by gentamicin-resistant Serratia marcescens. J Hosp Infect (1982) 1.06
Corrosive esophagitis in children: a 30-year review. Int J Pediatr Otorhinolaryngol (2001) 1.06
Pulmonary lesions due to opportunist mycobacteria. (Review includes 30 cases of M. kansasii infections). Clin Radiol (1975) 1.06
Detection of antibodies in human sera to the repeating epitope of the circumsporozoite protein of Plasmodium falciparum using the synthetic peptide (NANP)3 in an enzyme-linked immunosorbent assay (ELISA). Am J Trop Med Hyg (1987) 1.06
High performance liquid chromatographic (HPLC) and other non-biological methods for quantitation of antifungal drugs. J Antimicrob Chemother (1982) 1.06
The control of movement in the preferred and non-preferred hands. Q J Exp Psychol (1979) 1.05
alpha-adrenoceptors in human peripheral lung. Eur J Pharmacol (1981) 1.05
Epidemiology of resistance in Neisseria gonorrhoeae. J Antimicrob Chemother (1986) 1.05
Computer-assisted determination of antibiotic susceptibility in photometer-read microtiter plates. J Clin Microbiol (1983) 1.05
Measuring patients' views of their health. SF 36 is suitable for elderly patients. BMJ (1993) 1.04
Investigation of an outbreak of ciprofloxacin-resistant Neisseria gonorrhoeae using a simplified opa-typing method. Epidemiol Infect (2001) 1.04
Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline. Genitourin Med (1995) 1.03
Relation between meconium concentration of the cocaine metabolite benzoylecgonine and fetal growth. J Pediatr (1995) 1.03
Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial. J Clin Microbiol (2009) 1.03
Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis. Br J Dermatol (1996) 1.02
Further localization of the gene for nevoid basal cell carcinoma syndrome (NBCCS) in 15 Australasian families: linkage and loss of heterozygosity. Am J Hum Genet (1993) 1.02
Differentiating between orchiectomized rats and controls using measurements of trabecular bone density: a comparison among DXA, histomorphometry, and peripheral quantitative computerized tomography. Calcif Tissue Int (1995) 1.02
Sportsman hernia: what can we do? Hernia (2010) 1.02
Objective tinnitus associated with abnormal mastoid emissary vein. J Otolaryngol (1989) 1.01
Hairy cell leukemia: a review. Medicine (Baltimore) (1978) 1.01
Immunisation of adults during an outbreak of diphtheria. Br Med J (Clin Res Ed) (1983) 1.00
Identification of Neisseria gonorrhoeae using the Neisstrip rapid enzyme detection test. J Clin Pathol (1991) 1.00
The adverse effect of dilution on the infectivity of Fusobacterium necrophorum culture. J Hyg (Lond) (1986) 1.00
The influence of bacterial vaginosis on in-vitro fertilization and embryo implantation during assisted reproduction treatment. Hum Reprod (1999) 1.00
Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer. Br J Cancer (2003) 0.99
The role of athletic trainers in counseling collegiate athletes. J Athl Train (1997) 0.99
Reduplicative paramnesia: possible anatomical and neuropsychological mechanisms. J Neurol Neurosurg Psychiatry (1988) 0.98
Factors affecting the toxicity of rotting carcasses containing Clostridium botulinum type E. Epidemiol Infect (1988) 0.98
Further evidence of dissemination of ability to produce penicillinase amongst gonococci. Lancet (1982) 0.98
Monocyte esterase? A factor involved in the pathogenesis of lymphoproliferative neoplasia. Leukemia (1987) 0.98
Comparison of false-positive reactions in direct-binding anti-HIV ELISA using cell lysate or recombinant antigens. Vox Sang (1990) 0.97
A 500-kilobase region containing the tuberous sclerosis locus (TSC1) in a 1.7-megabase YAC and cosmid contig. Genomics (1995) 0.97
Candidosis of the genital tract in non-pregnant women. Eur J Obstet Gynecol Reprod Biol (1985) 0.96
Regional hip blockade in osteoarthrosis. Effects on pain perception. Anaesthesia (1982) 0.94